Article Versions Notes

Bui QL, Mas L, Hollebecque A, Tougeron D, de la Fouchardière C, Pudlarz T, Alouani E, Guimbaud R, Taieb J, André T, et al. Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer. Cancers. 2022; 14(2):406. https://doi.org/10.3390/cancers14020406

Bui, Quang Loc, Léo Mas, Antoine Hollebecque, David Tougeron, Christelle de la Fouchardière, Thomas Pudlarz, Emily Alouani, Rosine Guimbaud, Julien Taieb, Thierry André, and et al. 2022. "Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer" Cancers 14, no. 2: 406. https://doi.org/10.3390/cancers14020406

Bui, Q. L., Mas, L., Hollebecque, A., Tougeron, D., de la Fouchardière, C., Pudlarz, T., Alouani, E., Guimbaud, R., Taieb, J., André, T., Colle, R., & Cohen, R. (2022). Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer. Cancers, 14(2), 406. https://doi.org/10.3390/cancers14020406